Novel Functional Peptide Nucleic Acid Monomer and Process for Producing the Same
Abstract
A compound represented by general formula (I) below; (in the formula, A denotes B denotes R denotes H, NO 2 , NH 2 , NHCbz, Br, F, Cl or SO 3 Na 2 , and n is an integer of 1 to 4 ), and a process for producing the above compound characterised in that it includes a reaction between an activated ester and a t-butoxycarbonylaminoethylamine or an ω-amino acid derivative.
Claims
exact text as granted — not AI-modified1 - 48 . (canceled)
49 . A process for producing a functional PNA monomer by reacting a t-butoxycarbonylaminoethylamine with a derivative of a functional molecule so as to incorporate the functional molecule into a PNA monomer, characterised in that the derivative of a functional molecule is an activated ester, wherein activated ester is characterised to have, on the carbonyl carbon forming the ester bond, a group represented by general formula (II) below,
(In the formula, A denotes
R denotes H, NO 2 , NH 2 , NHCbz, Br, F, Cl or SO 3 Na 2 , and n is an integer of 1 to 4.),
and, is characterised to have, on its carbonyl carbon, a pentafluorophenoxy group or a succinimidoxy group.
50 . A process for producing the activated ester according to claim 49 , characterised in that it comprises reacting a carboxylic acid derivative of a functional molecule with a compound having a pentafluorophenoxy group or a succinimidoxy group.
51 . A process for producing the carboxylic acid derivative of a functional molecule according to claim 52 , characterised in that it comprises reacting a derivative of the functional molecule with an aliphatic carboxylic acid.
52 . A process for producing a functional PNA monomer by reacting a derivative of a functional molecule, including following chemical formula (IV) at the terminal of molecule, with an ω-amino acid derivative represented by general formula (III) below, thereby incorporating the functional molecule into a PNA monomer, characterised in that the derivative of the functional molecule is an activated ester:
(In the formula, R 1 denotes a hydrogen atom or a straight- or branched-chain C 1 to C 5 alkyl group, and m denotes an integer of 1 to 11.),
53 . The production process according to claim 52 , characterised in that the activated ester has, on its carbonyl group forming an ester bond, a group represented by general formula (II) below, either directly or via an aliphatic chain or a peptide chain:
(In the formula, A denotes
R denotes H, NO 2 , NH 2 , NHCbz, Br, F, Cl or SO 3 Na 2 , and n is n integer of 1 to 4.).
54 . The production process according to claim 52 , characterised in that the activated ester has, on its carbonyl carbon, a pentafluorophenoxy group or a succinimidoxy group.
55 . The production process according to claim 53 , characterised in that the activated ester has, on its carbonyl carbon, a pentafluorophenoxy group or a succinimidoxy group.Join the waitlist — get patent alerts
Track US2008138817A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.